• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD Q-SYTE¿ LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD Q-SYTE¿ LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385100
Device Problem Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/29/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the bd q-syte" luer access split-septum stand-alone device had tears around the silicone seal after sterilization.The following information was provided by the initial reporter: "reported there are tears around the silicone seal after sterilization, no patient involvement.".
 
Event Description
It was reported that the bd q-syte¿ luer access split-septum stand-alone device had tears around the silicone seal after sterilization.The following information was provided by the initial reporter: "reported there are tears around the silicone seal after sterilization, no patient involvement.".
 
Manufacturer Narrative
The following fields were updated due to additional information: d.9.Device available for eval?: yes.D.9.Returned to manufacturer on: 9/27/2021.H.6.Investigation: our quality engineer inspected the samples and photographs submitted for evaluation.Bd received fourteen units without packaging and five photos from an internal investigation.Visual inspection of the returned samples found that all units had the top disk detached from the q-syte top body.Based on the provided internal investigation, all of the returned units were detached using a scalpel.All units were tested for leakage in both the actuated and unactuated positions.Testing found that none of the units leaked in either position, likely indicating that no column tears were present on the units.Further inspection was performed by checking for column defects and no column defects were identified.The units were then dissected and microscopic inspection was performed.There was evidence of cured adhesive around the rim of the fourteen q-sytes, indicating that the septum top disk had been properly adhered to the q-syte during manufacturing.All 14 units showed evidence of a material residue running along the length of the inside of the top body where the column of the septum meets the top body inner wall, an occurrence know as wicking.One of the units had the column still adhered to the inner wall of the top body, confirming that the material residue observed on the other units was most likely adhesive.Although none of the units had tears that went through the septum material, all units exhibited thinning of the wall material.The location of the thinning coincided with the location of the adhesive which likely indicated that detachment of the column from the adhesive may have happened postproduction, likely during the internal investigation.On all 14 units there was evidence of additional column damage directly underneath the top disk and running parallel to the top disk although this may have been caused by the scalpel or by stretching the material using tweezers as both instruments were indicated to have been used during the internal investigation to detach the top disk from the top body.Based this investigation, bd was able to confirm the occurrence of adhesive wicking which is related to the manufacturing process.Bd was unable to confirm any leakage.The septum is designed to minimize wicking of the adhesive down the column; however, this type of defect may still occur and may potentially result in leakage when exacerbated by excessive actuations.Although wicking was confirmed in the fourteen returned units, no leakage was observed.A device history record review showed no non-conformances associated with this issue during the production of this batch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE¿ LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE
Type of Device
INTRAVASCULAR ADMINISTRATION SET
MDR Report Key12374144
MDR Text Key268362826
Report Number9610847-2021-00400
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30382903851004
UDI-Public30382903851004
Combination Product (y/n)N
PMA/PMN Number
K013621
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,other
Type of Report Initial,Followup
Report Date 10/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/26/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number385100
Device Catalogue Number385100
Device Lot Number0119940
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/27/2021
Date Manufacturer Received10/13/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-